Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - LEGACY LIFEPOINT HEALTH, INC. | g27545exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 17, 2011 (June 15, 2011)
LIFEPOINT HOSPITALS, INC.
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation) |
000-51251 (Commission File Number) |
20-1538254 (IRS Employer Identification No.) |
103 Powell Court Brentwood, Tennessee (Address of principal executive offices) |
37027 (Zip Code) |
(615) 372-8500
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instruction A.2. below):
o | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 | Other Events. |
On September 15, 2010, LifePoint Hospitals, Inc. (the Company) issued a press release announcing
that its Board of Directors has authorized a stock repurchase program of up to $150 million of the
Companys common stock over an 18 month period (the Repurchase Authorization).
Pursuant to this Repurchase Authorization, the Company may repurchase shares authorized under its
stock repurchase program, if at all, through open market purchases or privately negotiated
transactions in accordance with applicable federal securities laws, including Rule 10b-18 of the
Securities Exchange Act of 1934 as amended (the Act).
Pursuant to the existing Repurchase Authorization, on June 15, 2011, the Company entered into a
trading plan in accordance with Rule 10b5-1 under the Act, to facilitate repurchases of its common
stock (the Plan) during its blackout period, which period commenced at the close of market on
June 15, 2011, if price targets in the Plan are met while the Plan is in place.
The Plan became effective on June 16, 2011 and will expire on August 2, 2011, unless terminated
earlier in accordance with its terms.
The Company does not retain or exercise any discretion over purchases of common stock under the
Plan.
Because repurchases under the Plan, if any, are subject to certain pricing parameters, there is no
guarantee as to the exact number of shares that will be repurchased under the Plan, or that there
will be any repurchases at all pursuant to the Plan.
See the Companys press release attached as Exhibit 99.1.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
99.1 | Copy of press release issued by the Company on June 17, 2011. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
LIFEPOINT HOSPITALS, INC. |
||||
By: | /s/ Paul D. Gilbert | |||
Name: | Paul D. Gilbert | |||
Title: | Executive Vice President, Chief Legal and Development Officer, Corporate Governance Officer and Secretary | |||
Date: June 17, 2011
EXHIBIT INDEX
Exhibit | ||
Number | Description | |
99.1 | Copy of press release issued by the Company on June 17, 2011. |